AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2020
May 20, 2020
35081_dirs_2020-05-20_e13d78d3-e770-4785-ac2d-1cc9052df0c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2019-07-05
Reporting Person: STERTZER SIMON H (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-02 | Common Stock | P | 41667 | $6 | Acquired | 91544 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-02 | Warrant (right to buy) | $6.30 | P | 41667 | Acquired | 2024-08-06 | Common Stock (41667) | Indirect |
Footnotes
F1: The original Form 4 omitted the issuance of these securities.
F2: The reported securities were included within 41,667 units purchased by Stertzer Holdings LLC for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock.
F3: These securities are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such securities.
More from BioCardia, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Director's Dealing
2026
Mar 27